MENU
NRC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NRC stock forecast, quote, news & analysis

NRC Health operates as a humanized healthcare and support organization... Show more

NRC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for NRC with price predictions
Aug 18, 2026

NRC's RSI Indicator ascends from oversold territory

The RSI Indicator for NRC moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2026. You may want to consider a long position or call options on NRC as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NRC just turned positive on August 11, 2026. Looking at past instances where NRC's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

NRC moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NRC crossed bullishly above the 50-day moving average on August 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

NRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NRC's P/B Ratio (74.074) is very high in comparison to the industry average of (7.245). NRC has a moderately high P/E Ratio (91.708) as compared to the industry average of (46.881). NRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.699). Dividend Yield (0.027) settles around the average of (0.044) among similar stocks. P/S Ratio (3.449) is also within normal values, averaging (6.174).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

A.I.Advisor
published Dividends

NRC paid dividends on July 10, 2026

National Research Corp NRC Stock Dividends
А dividend of $0.16 per share was paid with a record date of July 10, 2026, and an ex-dividend date of June 26, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.77B. The market cap for tickers in the group ranges from 708 to 39.43B. VEEV holds the highest valuation in this group at 39.43B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 4%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 25%. HTFL experienced the highest price growth at 53%, while ONMD experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 89%. For the same stocks of the Industry, the average monthly volume growth was 184% and the average quarterly volume growth was 38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 53
SMR Rating: 87
Profit Risk Rating: 98
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
NRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of market research services for the healthcare industry

Industry ServicestotheHealthIndustry

Profile
Details
Industry
Servicestothe Health Industry
Address
5601 South 59th Street
Phone
+1 800 388-4264
Employees
357
Web
https://www.nrchealth.com
NRC's RSI Indicator ascends from oversold territory